completed

The objective of the HART study was to evaluate the effects of homocysteine-lowering vitamin therapy on the progression of carotid atherosclerosis, as evaluated by serial B-mode quantitative ultrasound (US) examinations.

HART was a sub-study of the HOPE-2 trial.

Primary endpoint:

Composite of CV death, myocardial infarction and stroke.

Study Type

Interventional - Drug

Study Design

Randomized, double-blind, placebo-controlled

NO. of Countries

1

NO. of Sites

10

NO. of Participants

923

Study Period

2000

Sponsor

PHRI

Back To Top